GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Common Stock

Immunoclin (Immunoclin) Common Stock : $0.03 Mil (As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Common Stock?

Immunoclin's quarterly common stock stayed the same from Apr. 2014 ($0.03 Mil) to Jul. 2014 ($0.03 Mil) but then increased from Jul. 2014 ($0.03 Mil) to Oct. 2014 ($0.03 Mil).

Immunoclin's annual common stock stayed the same from Feb. 2012 ($0.01 Mil) to Jan. 2013 ($0.01 Mil) but then increased from Jan. 2013 ($0.01 Mil) to Jan. 2014 ($0.03 Mil).


Immunoclin Common Stock Historical Data

The historical data trend for Immunoclin's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Common Stock Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Common Stock
0.01 0.01 0.03

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.03 0.03 0.03

Immunoclin Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Immunoclin (Immunoclin) Business Description

Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines